Optieum Biotechnologies

Matsuyama-shi, Japan

OB is a biotechnology company committed to developing innovative scfv antibody based therapies for the treatment of patients with cancers.

Apr 2026

Venture - Series Unknown

Biotechnology Medical Therapeutics

Top Investors

ANRI UntroD Capital Keio Innovation Initiative Iyogin Capital Vision Incubate

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Optieum Biotechnologies

Who are Optieum Biotechnologies's investors?

Optieum Biotechnologies's investors include ANRI, UntroD Capital, Keio Innovation Initiative, Iyogin Capital, Vision Incubate.

Where is Optieum Biotechnologies headquartered?

Optieum Biotechnologies is headquartered in Matsuyama-shi, Japan.

What does Optieum Biotechnologies do?

OB is a biotechnology company committed to developing innovative scfv antibody based therapies for the treatment of patients with cancers.

What stage is Optieum Biotechnologies at?

Optieum Biotechnologies is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 1, 2026.

MLA

"Optieum Biotechnologies — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/optieum-biotechnologies. Accessed July 2, 2026.

APA

VCBacked. (2026). Optieum Biotechnologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/optieum-biotechnologies

Wikipedia (cite web)

{{cite web |title=Optieum Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/optieum-biotechnologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 1, 2026.